These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 16643321)
1. The search for cerebral biomarkers of Huntington's disease: a review of genetic models of age at onset prediction. Squitieri F; Ciarmiello A; Di Donato S; Frati L Eur J Neurol; 2006 Apr; 13(4):408-15. PubMed ID: 16643321 [TBL] [Abstract][Full Text] [Related]
2. [Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea]. Vojvodić N; Culjković B; Romac S; Stojković O; Sternić N; Sokić D; Kostić VS Srp Arh Celok Lek; 1998; 126(3-4):77-82. PubMed ID: 9863360 [TBL] [Abstract][Full Text] [Related]
3. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Langbehn DR; Brinkman RR; Falush D; Paulsen JS; Hayden MR; Clin Genet; 2004 Apr; 65(4):267-77. PubMed ID: 15025718 [TBL] [Abstract][Full Text] [Related]
4. CAG mutation effect on rate of progression in Huntington's disease. Squitieri F; Cannella M; Simonelli M Neurol Sci; 2002 Sep; 23 Suppl 2():S107-8. PubMed ID: 12548366 [TBL] [Abstract][Full Text] [Related]
5. Age, CAG repeat length, and clinical progression in Huntington's disease. Rosenblatt A; Kumar BV; Mo A; Welsh CS; Margolis RL; Ross CA Mov Disord; 2012 Feb; 27(2):272-6. PubMed ID: 22173986 [TBL] [Abstract][Full Text] [Related]
6. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Wexler NS; Lorimer J; Porter J; Gomez F; Moskowitz C; Shackell E; Marder K; Penchaszadeh G; Roberts SA; Gayán J; Brocklebank D; Cherny SS; Cardon LR; Gray J; Dlouhy SR; Wiktorski S; Hodes ME; Conneally PM; Penney JB; Gusella J; Cha JH; Irizarry M; Rosas D; Hersch S; Hollingsworth Z; MacDonald M; Young AB; Andresen JM; Housman DE; De Young MM; Bonilla E; Stillings T; Negrette A; Snodgrass SR; Martinez-Jaurrieta MD; Ramos-Arroyo MA; Bickham J; Ramos JS; Marshall F; Shoulson I; Rey GJ; Feigin A; Arnheim N; Acevedo-Cruz A; Acosta L; Alvir J; Fischbeck K; Thompson LM; Young A; Dure L; O'Brien CJ; Paulsen J; Brickman A; Krch D; Peery S; Hogarth P; Higgins DS; Landwehrmeyer B; Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3498-503. PubMed ID: 14993615 [TBL] [Abstract][Full Text] [Related]
7. [Analysis of trinucleotide repeat expansion as a new mechanism of mutation in Huntington's chorea: theoretical and applied aspects]. Illarioshkin SN; Ivanova-Smolenskaia IA; Markova ED; Nikol'skaia NN; Chabrashvili TZ; Insarova NG Genetika; 1996 Jan; 32(1):103-9. PubMed ID: 8647411 [TBL] [Abstract][Full Text] [Related]
8. [Huntington's chorea: clinical aspects, genetics and current diagnosis]. Spiegel R Ther Umsch; 1995 Dec; 52(12):814-20. PubMed ID: 8539653 [TBL] [Abstract][Full Text] [Related]
9. A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion. Margolis RL; O'Hearn E; Rosenblatt A; Willour V; Holmes SE; Franz ML; Callahan C; Hwang HS; Troncoso JC; Ross CA Ann Neurol; 2001 Sep; 50(3):373-80. PubMed ID: 11558794 [TBL] [Abstract][Full Text] [Related]
10. [Direct genetic diagnosis in Huntington's chorea]. Spiegel R; Weigell-Weber M; Hergersberg M; Schmid W Schweiz Med Wochenschr; 1993 Dec; 123(48):2271-7. PubMed ID: 8272801 [TBL] [Abstract][Full Text] [Related]
11. Trinucleotide repeat length and rate of progression of Huntington's disease. Illarioshkin SN; Igarashi S; Onodera O; Markova ED; Nikolskaya NN; Tanaka H; Chabrashwili TZ; Insarova NG; Endo K; Ivanova-Smolenskaya IA Ann Neurol; 1994 Oct; 36(4):630-5. PubMed ID: 7944295 [TBL] [Abstract][Full Text] [Related]
12. Huntington's Disease-like 2 (HDL2) in North America and Japan. Margolis RL; Holmes SE; Rosenblatt A; Gourley L; O'Hearn E; Ross CA; Seltzer WK; Walker RH; Ashizawa T; Rasmussen A; Hayden M; Almqvist EW; Harris J; Fahn S; MacDonald ME; Mysore J; Shimohata T; Tsuji S; Potter N; Nakaso K; Adachi Y; Nakashima K; Bird T; Krause A; Greenstein P Ann Neurol; 2004 Nov; 56(5):670-4. PubMed ID: 15468075 [TBL] [Abstract][Full Text] [Related]
13. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Andrew SE; Goldberg YP; Kremer B; Telenius H; Theilmann J; Adam S; Starr E; Squitieri F; Lin B; Kalchman MA Nat Genet; 1993 Aug; 4(4):398-403. PubMed ID: 8401589 [TBL] [Abstract][Full Text] [Related]
15. What is the impact of education on Huntington's disease? López-Sendón JL; Royuela A; Trigo P; Orth M; Lange H; Reilmann R; Keylock J; Rickards H; Piacentini S; Squitieri F; Landwehrmeyer B; Witjes-Ane MN; Jurgens CK; Roos RA; Abraira V; de Yébenes JG; Mov Disord; 2011 Jul; 26(8):1489-95. PubMed ID: 21432905 [TBL] [Abstract][Full Text] [Related]
16. [Expansion of triplet repeat and neurodegenerative disorders]. Kanazawa I Rinsho Shinkeigaku; 1994 Dec; 34(12):1224-6. PubMed ID: 7774118 [TBL] [Abstract][Full Text] [Related]
17. Effect of CAG repeat length on psychiatric disorders in Huntington's disease. Vassos E; Panas M; Kladi A; Vassilopoulos D J Psychiatr Res; 2008 Jun; 42(7):544-9. PubMed ID: 17610899 [TBL] [Abstract][Full Text] [Related]
18. Trinucleotide repeat length instability and age of onset in Huntington's disease. Duyao M; Ambrose C; Myers R; Novelletto A; Persichetti F; Frontali M; Folstein S; Ross C; Franz M; Abbott M Nat Genet; 1993 Aug; 4(4):387-92. PubMed ID: 8401587 [TBL] [Abstract][Full Text] [Related]
19. De novo expansion of a (CAG)n repeat in sporadic Huntington's disease. Myers RH; MacDonald ME; Koroshetz WJ; Duyao MP; Ambrose CM; Taylor SA; Barnes G; Srinidhi J; Lin CS; Whaley WL Nat Genet; 1993 Oct; 5(2):168-73. PubMed ID: 8252042 [TBL] [Abstract][Full Text] [Related]
20. The association of CAG repeat length with clinical progression in Huntington disease. Rosenblatt A; Liang KY; Zhou H; Abbott MH; Gourley LM; Margolis RL; Brandt J; Ross CA Neurology; 2006 Apr; 66(7):1016-20. PubMed ID: 16606912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]